Cargando…
Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT)
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370377/ https://www.ncbi.nlm.nih.gov/pubmed/35967099 http://dx.doi.org/10.1093/noajnl/vdac090 |
| _version_ | 1784766776753520640 |
|---|---|
| author | Howden, Kaitlyn McDonald, Patrick J Kazina, Colin Ong, Annie Ho, Ben Huang, Annie Orr, Brent A Vanan, Magimairajan Issai |
| author_facet | Howden, Kaitlyn McDonald, Patrick J Kazina, Colin Ong, Annie Ho, Ben Huang, Annie Orr, Brent A Vanan, Magimairajan Issai |
| author_sort | Howden, Kaitlyn |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9370377 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93703772022-08-12 Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) Howden, Kaitlyn McDonald, Patrick J Kazina, Colin Ong, Annie Ho, Ben Huang, Annie Orr, Brent A Vanan, Magimairajan Issai Neurooncol Adv Molecular Tumor Board Case Report Oxford University Press 2022-06-07 /pmc/articles/PMC9370377/ /pubmed/35967099 http://dx.doi.org/10.1093/noajnl/vdac090 Text en © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Molecular Tumor Board Case Report Howden, Kaitlyn McDonald, Patrick J Kazina, Colin Ong, Annie Ho, Ben Huang, Annie Orr, Brent A Vanan, Magimairajan Issai Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) |
| title | Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) |
| title_full | Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) |
| title_fullStr | Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) |
| title_full_unstemmed | Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) |
| title_short | Sustained and durable response with Alisertib monotherapy in the treatment of relapsed Atypical Teratoid Rhabdoid Tumor (ATRT) |
| title_sort | sustained and durable response with alisertib monotherapy in the treatment of relapsed atypical teratoid rhabdoid tumor (atrt) |
| topic | Molecular Tumor Board Case Report |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9370377/ https://www.ncbi.nlm.nih.gov/pubmed/35967099 http://dx.doi.org/10.1093/noajnl/vdac090 |
| work_keys_str_mv | AT howdenkaitlyn sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt AT mcdonaldpatrickj sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt AT kazinacolin sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt AT ongannie sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt AT hoben sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt AT huangannie sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt AT orrbrenta sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt AT vananmagimairajanissai sustainedanddurableresponsewithalisertibmonotherapyinthetreatmentofrelapsedatypicalteratoidrhabdoidtumoratrt |